Kunkel Lori Anne
Insider CIK 1536368 · CRIS Director · TOCA Acting-Chief Medical Officer, Director · NRIX Director · LOXO Director · ELVN Director · ORIC Director · PCYC Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-06 | 2026-07-08 | 4,111 | $49.98 | $205.5K | 47,773 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-06 | 2026-07-08 | 5,889 | $50.84 | $299.4K | 41,884 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-05 | 2026-06-09 | 1,867 | $35.36 | $66.0K | 52,238 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-05 | 2026-06-09 | 7,779 | $34.28 | $266.7K | 54,105 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-05 | 2026-06-09 | 354 | $35.82 | $12.7K | 51,884 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 17,126 | — | $0 | 17,126 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-12-17 | 2025-12-19 | 15,958 | — | $0 | 3,741 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-12-17 | 2025-12-19 | 15,958 | $1.12 | $17.9K | 30,712 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-08 | 2025-12-09 | 10,000 | — | $0 | 15,600 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-12-08 | 2025-12-09 | 10,000 | $7.90 | $79.0K | 84,200 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-04 | 2025-12-05 | 5,534 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-12-04 | 2025-12-05 | 5,534 | $3.75 | $20.8K | 74,200 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-04 | 20,500 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-04 | 27,666 | — | $0 | 5,534 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 27,666 | $3.75 | $103.7K | 48,166 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 20,500 | $6.33 | $129.8K | 68,666 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 15,368 | — | $0 | 15,368 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | G Gift | 2024-07-17 | 2024-07-18 | 54,027 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 25,600 | — | $0 | 25,600 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-06-03 | 2024-06-04 | 20,500 | — | $0 | 33,200 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2024-06-03 | 2024-06-04 | 20,500 | $3.75 | $76.9K | 20,500 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2024-05-20 | 2024-05-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-04-08 | 2024-04-10 | 37,882 | — | $0 | 37,882 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-06-17 | 2022-06-17 | 53,700 | — | $0 | 53,700 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-05-05 | 2022-05-06 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 16,625 | — | $0 | 16,625 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2021-05-06 | 2021-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2021-01-28 | 2021-01-29 | 33,000 | — | $0 | 33,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2020-06-09 | 2020-06-10 | 28,515 | — | $0 | 28,515 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2020-03-02 | 2020-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 11,000 | $235.00 | $2.58M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 4,716 | $235.00 | $1.11M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 49,687 | $235.00 | $11.68M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 27,344 | $235.00 | $6.43M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 3,095 | $235.00 | $727.3K | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 8,750 | $235.00 | $2.06M | 0 | SEC↗ |
| CRIS CURIS INC | S Sale | 2019-01-23 | 2019-01-25 | 14,800 | $1.05 | $15.5K | 22,200 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2019-01-21 | 2019-01-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-01-11 | 2019-02-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-10-01 | 2018-10-03 | 5,000 | — | $0 | 22,344 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-10-01 | 2018-10-03 | 500 | $171.90 | $86.0K | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-10-01 | 2018-10-03 | 5,000 | $3.65 | $18.3K | 5,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-10-01 | 2018-10-03 | 4,500 | $170.20 | $765.9K | 500 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-15 | 2018-06-18 | 4 | $177.79 | $711 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-15 | 2018-06-18 | 5,601 | $177.12 | $992.0K | 4 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-15 | 2018-06-18 | 1,235 | $175.64 | $216.9K | 5,605 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-14 | 2018-06-18 | 3,096 | — | $0 | 4,716 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-14 | 2018-06-18 | 1,953 | — | $0 | 5,859 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-14 | 2018-06-18 | 27,343 | — | $0 | 27,344 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-14 | 2018-06-18 | 3,096 | $20.91 | $64.7K | 37,279 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-14 | 2018-06-18 | 27,343 | $3.65 | $99.8K | 34,183 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-14 | 2018-06-18 | 1,953 | $24.18 | $47.2K | 39,232 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-14 | 2018-06-18 | 28,440 | $180.28 | $5.13M | 10,792 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-14 | 2018-06-18 | 2,411 | $181.48 | $437.5K | 8,381 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-14 | 2018-06-18 | 1,541 | $182.35 | $281.0K | 6,840 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 8,750 | — | $0 | 8,750 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-04-20 | 2018-04-24 | 900 | $131.98 | $118.8K | 10,940 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-04-20 | 2018-04-24 | 4,000 | $132.81 | $531.2K | 6,940 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-04-20 | 2018-04-24 | 100 | $133.60 | $13.4K | 6,840 | SEC↗ |
| CRIS CURIS INC | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 185,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-02 | 2017-11-06 | 2,800 | $85.21 | $238.6K | 12,240 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-02 | 2017-11-06 | 400 | $86.28 | $34.5K | 11,840 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-02 | 2017-11-06 | 1,800 | $84.15 | $151.5K | 15,040 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-08-22 | 2017-08-23 | 10,000 | $75.17 | $751.7K | 16,840 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2017-04-12 | 2017-04-12 | 4,528 | — | $0 | 4,528 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2016-11-11 | 2016-11-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2016-06-10 | 2016-06-13 | 7,812 | — | $0 | 7,812 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-07-28 | 2015-07-30 | 7,812 | — | $0 | 7,812 | SEC↗ |
| PCYC PHARMACYCLICS INC | J Other | 2013-04-30 | 2013-05-01 | 921 | $23.07 | $21.2K | 2,842 | SEC↗ |
| PCYC PHARMACYCLICS INC | J Other | 2012-10-31 | 2012-11-02 | 921 | $23.07 | $21.2K | 1,921 | SEC↗ |